Clinical Characteristics of Noncritical Patients with Coronavirus Disease 2019 (COVID-19): Lessons from Bangladesh

Abstract

The scientific literatures on clinical manifestations of coronavirus disease 2019 (COVID-19) patients from South Asian countries including Bangladesh are limited. Documentation of clinical spectrum from various geographic locations is vital for future scientific studies and clinical management. This study is aimed to report the sociodemographic and clinical characteristics of noncritical patients with COVID-19 in Bangladesh. We conducted a cross-sectional study at three dedicated COVID-19 hospitals of Bangladesh. The severity of the COVID-19 cases was assessed based on the WHO interim guidance. Data were collected only from non-critical COVID-19 patients as critical patients required immediate management. A total of 103 real-time polymerase chain reaction (RT-PCR) confirmed noncritical COVID- 19 patients were included. Most of the patients (71.8%) were male. Mild, moderate and severe illness were assessed in 74.76%, 9.71% and 15.53% of patients respectively. Nearly 52.4% patients had a co-morbidity, with hypertension being the most common (34%), followed by diabetes mellitus (21.4%) and ischemic heart disease (9.7%). Fever (78.6%), weakness (68%) and cough (44.7%) were the most common clinical manifestations. Other common symptoms included loss of appetite (37.9%), difficulty in breathing (37.9%), loss of taste or smell (35.0%), headache (32%) and body ache (32%). The median time from onset of the first symptom to attending hospitals was 7 days (interquartile range: 4 - 10). This study will help both the clinicians and epidemiologists to understand the magnitude and clinical spectrum of COVID-19 patients in South Asian perspective including Bangladesh.
 Bangladesh J Microbiol, Volume 37 Number 2 December 2020, pp 42-46

Why COVID-19 symptomatic patients did not seek healthcare service in Bangladesh: Evidence from a cross-sectional study

“…The symptomatic pro le of the participants in this study corresponds to another study conducted among Bangladeshi patients and is also similar to ndings observed in China, Japan, Spain, Italy, and the USA as fever being the most common symptom whereas studies from Australia, the UK, Iceland, and a few other European countries showed cough as the most prevalent symptom [27,28]. A recent study showed that there is no signi cant association between the SARS-CoV-2 new variants and the symptoms, which indicates that the variation in symptoms across different geographic regions is likely due to outcomes of complex host-pathogen interactions [29].…”

Clinical Characteristics of Deceased with COVID-19 Infection: Data from the Largest COVID-19 Dedicated Hospital in Bangladesh

“…In Bangladesh, there is limited information regarding the clinical characteristics of hospitalized COVID-19 patients who die or survive. 12,13 It is necessary to identify factors that are predictive of mortality in this setting. Therefore, this study was conducted at Dhaka Medical College Hospital to determine the demographic profile, clinical presentation, and laboratory parameters of COVID-19 patients admitted to this center who died or were discharged alive to determine the predictors of mortality.…”